FDA Approved: LEVETIRACETAM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application to authorize Levetiracetam in sodium chloride for intravenous use, manufactured by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizure Disorders

Drugs mentioned

• Levetiracetam in Sodium Chloride (IV formulation) (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM IN SODIUM CHLORIDE)